Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy

• Status: Not yet recruiting
• Trial end date: 2024-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the efficacy of lactoferrin as an adjunct therapy in improving clinical symptoms and laboratory indices in individuals with hepatic encephalopathy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Al-Azhar University
• Treatments: Lactoferrin

Criteria

Inclusion Criteria:

• 18 years and older.

• Grade I and II hepatic encephalopathy.

Exclusion Criteria:

• Pregnant and breastfeeding women.

• Grade III and IV hepatic encephalopathy.

• Individuals confirmed to be allergic to milk protein